Predictive Markers of Efficacy for an Angiopoietin-2 Targeting Therapeutic in Xenograft ModelsGallen Triana‐Baltzer(Johnson & Johnson (United States))PLoS ONENovember 14, 201310.1371/journal.pone.0080132Cited by 6SaveCiteExport RISWatch citationsRelated PapersAssociation of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography|JAMA Neurology|2022|261A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests|Brain|2024|95Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer’s disease spectrum|Brain|2025|22